Monographs: Pharmaceutical substances: Norethisterone (Norethisteronum)

Molecular formula. C20H26O2

Relative molecular mass. 298.4

Graphic formula

Chemical name. 17-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one; CAS Reg. No. 68-22-4.

Description. A white or almost white, crystalline powder.

Solubility. Practically insoluble in water; soluble in dichloromethane, sparingly soluble in acetone and in anhydrous ethanol.

Category. Progestational steroid.

Storage. Norethisterone should be kept in a well-closed container, protected from light.

Requirements

Definition. Norethisterone contains not less than 97.0% and not more than not more than 102.0% (“Assay”, method A) or not less than 98.0% and not more than 101.0% (“Assay”, method B) of C20H26O2, calculated with reference to the dried substance.

Identity tests

Either test A alone or the tests B, D and E or C, D and E may be applied.

A. Carry out the examination as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from norethisterone RS or with the reference spectrum of norethisterone.

B. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R1 as the coating substance and a mixture of 95 volumes of dichloromethane R and 5 volumes of methanol R as the mobile phase. Apply separately to the plate 10 µL of each of the following 3 solutions in dehydrated ethanol R containing (A) 0.2 mg of the test substance per mL, (B) 0.2 mg of norethisterone RS per mL and (C) 0.2 mg of norethisterone RS and 0.2 mg ethinylestradiol RS per mL. Develop the plate. After removing the plate from the chromatographic chamber allow it to dry in air or in a current of air and spray the plate with sulfuric acid/ethanol (10%) TS. Heat the plate to 105 °C for 10 minutes, allow it to cool and examine the chromatogram in ultraviolet light (365 nm). The principal spot in the chromatogram obtained with solution (A) corresponds in position, appearance and intensity with that obtained with solution (B). The test is not valid unless the chromatogram obtained with solution (C) shows two clearly separated spots.

C. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using the conditions given under “Related substances”. The retention time of the principal peak in the chromatogram obtained with solution (1) corresponds to the retention time of the principal peak in the chromatogram obtained with solution (3).

D. Dissolve about 10 mg in 1 mL of dehydrated ethanol R. Add silver nitrate (100 g/L) TS and shake; a white precipitate is produced.

E. Dissolve about 10 mg of the sample in 50 mL of dehydrated ethanol R and dilute to 100.0 mL with the same solvent, dilute 5.0 mL of this solution to 50.0 mL with dehydrated ethanol R. The absorption spectrum (1.6) of the solution, when observed between 200 nm and 400 nm, exhibits a maximum at about 240 nm; the specific absorbance () at 240 nm is between 510 and 630).

Specific optical rotation (1.4). Use a 10 mg per mL solution in acetone R and calculate with reference to the anhydrous substance; = -32° to -37°.

Sulfated ash (2.3). Not more than 1.0 mg/g.

Loss on drying. Dry to constant weight at 105 °C; it loses not more than 5.0 mg/g.

Related substances. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (15 cm x 4.6 mm) packed with end-capped particles of silica gel, the surface of which has been modified with chemically-bonded octylsilyl groups (5 µm).

Use the following conditions for gradient elution:

mobile phase A: water R;

mobile phase B: acetonitrile R.

Time
(min)

Mobile phase A
(% v/v)

Mobile phase B
(% v/v)

Comments

0–20

63

37

Isocratic

20–25

63 to 20

37 to 80

Linear gradient

25–35

20

80

Isocratic

35–36

20 to 63

80 to37

Return to initial composition

36–45

63

37

Re-equilibration

Operate with a flow rate of 1.0 mL per minute. As a detector use a variable wavelength spectrophotometer set at a wavelength of 254 nm and, for impurities C, D and I, at 210 nm.

Prepare the following solutions using as the diluent a mixture of 40 volumes of water R and 60 volumes of acetonitrile R. For solution (1) dissolve about 25 mg of the test substance and dilute to 10.0 mL. For solution (2) dilute 1.0 mL of solution (1) to 100.0 mL. Dilute 1.0 mL of this solution to 10.0 mL. For solution (3) dissolve 5.0 mg of norethisterone for system suitability RS (containing the impurities A, B, C, D, E, F, G and H) and dilute to 2.0 mL. For solution (4) use a solution containing about 2.5 µg of ethinylestradiol RS (impurity I) per mL.

Inject solution 20 µL of solution (3). The test is not valid unless in the chromatogram recorded at the wavelength of 254 nm the peaks due to impurity B (with a relative retention of about 0.9) and due to norethisterone (retention time about 10 minutes) are baseline separated and the peak-to-valley ratio (Hp/Hv) is at least 1.2, where Hp is the height above the baseline of the peak due to impurity A (with a relative retention of about 0.8) and Hv is the the height above the baseline of the lowest point of the curve separating this peak from the peak due to impurity B.

Inject alternately 20 µL each of solution (1), (2) and (4)

Use the chromatogram obtained with solution (3) and the chromatogram supplied with norethisterone for system suitability RS to identify the peaks due to the impurities A, B, C, D, E, F, G and H. Use the chromatogram obtained with solution (4) to identify the peak due to impurity I. The impurities are eluted at the following relative retention with reference to norethisterone (retention time about 10 minutes): impurity H about 0.3; impurity A about 0.8; impurity B about 0.9; impurity I about 1.1 (at 210 nm); impurity G about 1.5; impurity C about 1.6 (at 210 nm); impurity D about 1.7 (at 210 nm); impurity E about 2.3; and impurity F about 2.4.

In the chromatogram obtained with solution (1):

  • the area of any peak corresponding to impurity A, when multiplied by a correction factor of 2.5, is not greater than the area of the principal peak obtained with solution (2) (0.1%);
  • the area of any peak corresponding to impurity B is not greater than the area of the principal peak obtained with solution (2) (0.1%);
  • the area of any peak corresponding to impurity E, when multiplied by a correction factor of 0.7, is not greater than 2 times the area of the principal peak obtained with solution (2) (0.2%);
  • the area of any peak corresponding to impurity F, when multiplied by a correction factor of 1.4, is not greater than the area of the principal peak obtained with solution (2) (0.1%);
  • the area of any peak corresponding to impurity H, when multiplied by a correction factor of 1.7, is not greater than 2 times the area of the principal peak obtained with solution (2) (0.2%);
  • the area of any peak corresponding to impurity G is not greater than 2 times the area of the principal peak obtained with solution (2) (0.2%);
  • the area of any peak corresponding to impurity C or D, recorded at 210 nm, is not greater than 2 times the area of the principal peak obtained with solution (2) (0.2%);
  • the area of any peak corresponding to impurity I, recorded at 210 nm, when multiplied by a correction factor of 0.2, is not greater than the area of the principal peak obtained with solution (2) (0.1%)
  • the area of any other peak, other than the principal peak due to norethisterone, is not greater than the area of the principal peak obtained with solution (2) (0.1%);
  • the sum of the corrected areas of any peak corresponding to impurity A, E, F and H and the areas of all other peaks recorded at 254 nm, other than the principal peak, is not greater than 3 times the area of the principal peak obtained with the solution (2) (0.3 %). Disregard any peak with an area less than 0.5 times the area of the principal peak obtained with solution (2) (0.05%).

Assay

  • Either method A or method B may be applied.

A. Dissolve about 0.01 g, accurately weighed, in sufficient dehydrated ethanol TS and dilute with the same solvent to 100.0 mL. Transfer 5.0 mL of this solution to a 50 mL volumetric flask and dilute to volume with the same solvent. Measure the absorbance (1.6) of the resulting solution in a 1 cm layer at about 240 nm. Calculate the percentage content of norethisterone (C20H26O2), using the absorptivity value of 57.1 ( = 571).

B. Dissolve about 0.20 g, accurately weighed, in 40 mL of tetrahydrofuran R. Add 10 mL of silver nitrate (100 g/L) TS and titrate with sodium hydroxide (0.1 mol/L) VS, determining the end-point potentiometrically. Rinse the electrode with acetone R after each titration. Carry out a blank determination and make any necessary correction.1 mL of 0.1 M sodium hydroxide is equivalent to 29.84 mg of C20H26O2.

Impurities

A. 17-hydroxy-19-nor-17α-pregna-4,6-dien-20-yn-3-one

B. estr-4-ene-3,17-dione (19-norandrostenedione)

C. 17-hydroxy-19-nor-17α-pregn-5-en-20-yn-3-one

D. 17-hydroxy-19-nor-17α-pregn-5(10)-en-20-yn-3-one (synthesis impurity)

E. 3-ethynyl-19-nor-17α-pregna-3,5-dien-20-yn-17-ol (synthesis impurity)

F. 3-ethoxy-19-nor-17α-pregna-3,5-dien-20-yn-17-ol

G. 17-hydroxy-19-norpregn-4-en-20-yn-3-one (17-epi-norethisterone)

H. 6β,17-dihydroxy-19-nor-17α-pregn-4-en-20-yn-3-one (6β-hydroxynorethisterone) (degradation product2)

I. 19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol (ethinylestradiol)

to previous sectionto next section